Evidence map›Paper›PMID 31429823›Full record

ArticleeLife2019

CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity.

Myo-Hyeon Park, Ae Kyung Kim, Sarala Manandhar, Su-Young Oh, Gun-Hyuk Jang, Li Kang, Dong-Won Lee, Do Young Hyeon, Sun-Hee Lee, Hye Eun Lee and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Matricellular protein CCN1 promotes collagen alignment and scar integrity after myocardial infarction.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Myo-Hyeon Park *BK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Ae Kyung Kim *BK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Sarala ManandharBK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Su-Young OhBK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Gun-Hyuk JangBK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Li KangBK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Dong-Won LeeDepartment of Biomedical Sciences, Korea University, Ansan Hospital, Ansan, Republic of Korea.
Do Young HyeonSchool of Interdisciplinary Bioscience and Bioengineering, POSTECH, Pohang, Republic of Korea.
Sun-Hee LeeBK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Hye Eun LeeBK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Tae-Lin HuhSchool of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu, Republic of Korea.
Sang Heon SuhDepartment of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea.
Daehee HwangDepartment of New Biology and Center for Plant Aging Research, DGIST, Daegu, Republic of Korea.
Kyunghee ByunGachon University, School of Medicine, Incheon, Republic of Korea.
Hae-Chul ParkDepartment of Biomedical Sciences, Korea University, Ansan Hospital, Ansan, Republic of Korea.
You Mie LeeBK21 Plus KNU Multi-Omics Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.ORCID 0000-0002-5756-7169
Kyungpook National University · KRKorea University · KRChonnam National University Hospital · KRDaegu Gyeongbuk Institute of Science and Technology · KRGachon University · KRPohang University of Science and Technology · KR

Funding

National Research Foundation of Korea NRF-2013R1A2A2A01068868National Research Foundation of Korea NRF-2017R1A2B3002227
6 · The paper itself

Abstract

CCN1 (CYR61) stimulates active angiogenesis in various tumours, although the mechanism is largely unknown. Here, we report that CCN1 is a key regulator of endothelial tip cell activity in angiogenesis. Microvessel networks and directional vascular cell migration patterns were deformed in

Indexed as

Neovascularization, PathologicSignal TransductionAnimalsCysteine-Rich Protein 61Endothelial CellsGene Expression RegulationHumansHuman Umbilical Vein Endothelial CellsIntegrin alphaVbeta3Mice, TransgenicProtein Interaction MapsVascular Endothelial Growth Factor Receptor-2ZebrafishCysteine-Rich Protein 61Integrin alphaVbeta3KDR protein, humanVascular Endothelial Growth Factor Receptor-2cell biologyCyr61developmental biologyintegrinαvβ3mouseVEGFR2YAP/TAZzebrafish

Identifiers

PMID31429823
PMCPMC6726423
OpenAlexW2969407665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.